Nearly two-thirds of multiple sclerosis  patients reported fatigue, half experienced pain in the first year after diagnosis.

A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.

Hesitation to put MS patients on the operating table, due to relapse risk, may have physicians delaying important surgeries unnecessarily.

People with multiple sclerosis often have trouble with memory, attention and mental processing. New research shows some of these issues could stem from sleep disorders.